Patients’ medical needs have no borders, and neither does our challenge to serve these patients. To provide treatment and extend our business as fast as we can, we work with a global network of members across various functions and regions.

*ASCA: In-house term referring to markets outside Japan, the United States, and Europe

Management Units

Corporate Units

Our five corporate units, Corporate Strategy, Corporate Planning & Management, Digital Transformation Management, Business Development, and Corporate Affairs support, our CEO in developing comprehensive and consistent corporate strategies and ensuring smooth management of the Daiichi Sankyo Group.

Functional Units

Our six functional units, Research & Development, Biologics, Pharmaceutical Technology, Supply Chain, Quality Assurance & Regulatory Affairs, and Clinical Safety & Pharmacovigilance, help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.

Business Units

Our six business units are responsible for strategic planning and execution in the regions of our business operations.

Japan Business Unit

Oncology Business Unit

EU Specialty Business Unit

ASCA Business Unit

American Regent Business Unit

Daiichi Sankyo Healthcare Unit